Dr. Blake C. Meyers' lab at UC Davis focuses on understanding small RNAs in plant reproduction, particularly in maize. The research explores how specific classes of small RNAs contribute to the development of male reproductive organs and their roles in male fertility. By using advanced imaging and genetic techniques, the lab aims to uncover the production, localization, and functions of these critical molecules in plants.

Dr. Adam Burgener's lab at Case Western Reserve University studies how the microbiome—the community of microbes living in our bodies—affects cervical cancer disparities, particularly among African American women. The lab investigates the relationship between vaginal microbiota and mucosal immunity to understand why African American women face higher rates of cervical cancer and explore new therapeutic approaches. Through advanced techniques, they aim to uncover mechanisms that contribute to cancer progression and identify potential new treatment targets.

Professor Marco Colonna's lab at Washington University focuses on the immune system's role in Alzheimer's Disease (AD) and other conditions. Researchers in the lab study how immune cells manage to clear harmful proteins like amyloid plaques and Tau aggregates in the brain. They are particularly interested in the function of microglia, a type of brain immune cell, and the receptor TREM2 which could be targeted for drug development to improve treatments for AD.

Dr. Anne-Ruxandra Carvunis' lab focuses on discovering the functions and evolutionary significance of microproteins, which are tiny proteins that have recently been found to be abundant but are often overlooked in genetic studies. They study how these microproteins evolve quickly and how the immune system influences their function, potentially linking them to autoimmune diseases. This research aims to better understand these previously unknown molecules, which could lead to new treatments for autoimmune conditions.

Dr. Vladimir I. Gelfand's lab at Northwestern University focuses on understanding how microtubules and the molecular motors that walk along them shape cell structure and function. By studying these mechanisms in different biological models like Drosophila oocytes and mammalian cells, the lab aims to discover how cells become polarized and how they transport vital components. These insights could lead to new treatments for neurodegenerative diseases and developmental defects in humans.

The Mitchison Lab at Harvard Medical School studies microtubules, which are essential structures in human cells that help with processes like cell division and neuron function. By using advanced imaging and biochemistry techniques, the lab aims to uncover how microtubules operate and interact in cells, and how they can be affected by diseases such as cancer and ALS. Their research could lead to new treatments for these conditions by targeting specific cellular mechanisms.

Dr. Richard A. Miller's lab at the University of Michigan focuses on understanding how certain interventions can extend the lifespan of mice, which may eventually lead to anti-aging treatments for humans. By testing different agents that affect aging processes, the lab hopes to discover new ways to promote health as we age. Their research uses a collaborative approach involving multiple institutions to test these interventions in a variety of settings, aiming to identify effective treatments that can delay age-related diseases.

Dr. David M. Miller's research lab at Vanderbilt University focuses on the molecular genetics of synaptic remodeling using the model organism C. elegans. The lab investigates how specific proteins, such as Neural Cell Adhesion Molecule (NCAM) and associated proteins like RIG-3, play essential roles in the formation and modification of neural connections. Ultimately, this work aims to uncover fundamental mechanisms that may also apply to synaptic plasticity in the human brain, shedding light on the genetic factors involved in learning and memory.

Dr. Paul S. Mischel's lab at Stanford University focuses on developing new treatments for glioblastoma, a highly aggressive brain cancer. The research aims to discover the proteins that glioblastoma cells depend on for survival, particularly when they have a mutated form of the epidermal growth factor receptor (EGFR). By using advanced chemical and proteomic techniques, the lab seeks to identify drug targets that can lead to more effective therapies for this challenging disease.

Dr. Brian Joseph Mitchell's lab at Northwestern University focuses on understanding primary ciliary dyskinesia (PCD), a genetic disorder that impacts respiratory health and other bodily functions. The research uses a unique model of ciliated cells from Xenopus embryos to explore how cilia develop and function. By identifying and characterizing new genes involved in PCD, the lab aims to improve diagnostic methods and enhance our understanding of this complicated condition.

Dr. Shilpa Iyer's lab at the University of Arkansas focuses on understanding mitochondrial disorders, particularly in children. The lab investigates how defects in mitochondrial DNA can lead to multiple organ failures through mechanisms such as oxidative stress and metabolic dysregulation. Their research aims to develop personalized therapies by studying the cellular and metabolic responses of affected tissues in pediatric patients.

Hiromi Sesaki's research lab at Johns Hopkins University focuses on understanding how mitochondria, the energy-producing structures in cells, maintain their shape and function. The lab explores how mitochondrial dynamics—such as their growth, division, and fusion—are regulated and how these processes are linked to various diseases including neurodegeneration and metabolic disorders. By investigating the molecular mechanisms involved, the lab aims to uncover new treatment strategies for diseases caused by mitochondrial dysfunction.

Dr. Cole Haynes' lab focuses on understanding how cells generate and maintain mitochondrial networks, especially as they relate to aging and age-related diseases like Alzheimer's and Parkinson's. By studying a specific transcription factor, ATFS-1, the lab aims to uncover the mechanisms that control mitochondrial function and biogenesis during development and throughout an organism's life. This research could help develop strategies for improving mitochondrial health in aging populations.

Dr. Erin Seifert's lab studies how fatty acids are processed by the body when mitochondrial function is impaired, specifically in conditions like mitochondrial myopathy. This research focuses on understanding how skeletal muscle, liver, and heart adapt to these deficiencies to manage energy production and cellular stress. Their ultimate goal is to identify new ways to support metabolic health in individuals with mitochondrial diseases.

Dr. Russell Norris's lab focuses on understanding mitral valve prolapse (MVP), a condition that can severely affect heart health. The lab investigates how MVP can lead to serious complications like left ventricular fibrosis and arrhythmias, emphasizing the importance of early diagnosis and treatment. By exploring the biological mechanisms behind MVP, the team aims to improve patient outcomes and develop better prevention strategies.

The research lab led by Dr. Marek Mlodzik focuses on understanding how cells achieve and maintain their polarized structures, which are crucial for proper organ development and function. A particular area of interest is the Wnt/Frizzled Planar Cell Polarity (PCP) signaling pathway, which has implications in various diseases, including cancer and developmental disorders. The lab conducts experiments primarily in Drosophila to explore the molecular mechanisms of cellular signaling and polarity establishment.

Dr. Diana Monsivais's lab focuses on developing new treatments for endometriosis, a painful condition affecting many women. Their innovative approach seeks to find non-hormonal therapies that can effectively target the disease mechanisms without impacting hormone levels. The lab combines expertise from various fields, including biochemistry and immunology, to create new medications that can help manage this condition more effectively.

Dr. Bradley S. Moore's lab at UC San Diego focuses on two major areas: understanding the health risks and benefits associated with seafood consumption through marine contaminants, and developing therapeutic applications for minor cannabinoids found in cannabis. The lab combines expertise from various fields to study both ocean health and innovative cannabinoid therapeutic potential, aiming to improve public health and environmental understanding.

Dr. Tara Moore's lab at Boston University Medical Campus focuses on using extracellular vesicles derived from mesenchymal stem cells to understand and potentially treat age-related cognitive decline and neurodegenerative diseases in primates. The research explores how these vesicles can enhance brain health by improving memory, reducing inflammation, and promoting tissue repair. A key aspect is studying the differences between male and female extracellular vesicles and their impact on brain recovery from injuries and age-related conditions.

Dr. Ann C. Morris's lab at the University of Kentucky specializes in studying the CHD7 gene, which is critical for proper eye development. By investigating how CHD7 influences retinal cell differentiation, the lab aims to understand the genetic basis of ocular defects like coloboma and the broader implications for congenital disorders such as CHARGE syndrome. Their research combines genetic models, advanced imaging, and transcriptomic analyses.